Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04790344 · ClinicalTrials.gov registry record · NA
LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.
A NA study of Heart Failure, sponsored by Boston Scientific Corporation.
- Active
- Registry status
- NA
- Development phase
- 525
- Enrollment target
- 20
- Study locations
NCT04790344: Active NA study of Heart Failure, sponsored by Boston Scientific Corporation.
NCT04790344 is a NA study of Heart Failure that is active but no longer recruiting, run by Boston Scientific Corporation. The registered enrollment target is 525 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (74% lower). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04790344, a NA study of Heart Failure, is active but no longer recruiting, sponsored by Boston Scientific Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 525 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to collect sensor data from insertable cardiac monitor systems.
Primary Outcome
Heart Failure (HF) event is defined as: * HF Hospitalization: subject is admitted with a calendar date change with signs/symptoms of congestive heart failure (CHF) and receives unscheduled augmented HF therapy with oral or intravenous medications, ultrafiltration therapy or other parenteral therapy. * HF Outpatient Visit: subject has signs/symptoms of CHF, and receives unscheduled intravenous decongestive therapy in a setting that does not involve a hospitalization with a calendar date change (
Conditions Studied
Interventions
- DEVICE Investigational LUX-Dx ICM Implant
Study Locations (20)
California
- John Muir Medical Center - Concord
- Scripps Memorial Hospital - La Jolla
- VA Loma Linda - Loma Linda
- Kaiser Permanenty Los Angeles Medical Center - Los Angeles
- University of California - Irvine - Orange
- San Diego Cardiac Center - San Diego
- Cardiology Associates Medical Group - Ventura
Florida
- The Cardiac and Vascular Institute - Gainesville
- North Florida South Georgia VA - Gainesville
- St. John's Center for Clinical Research (First Coast Heart and Vascular Center, PLLC) - Jacksonville
- Village Heart and Vein Center - Lady Lake
- Naples Heart and Rhythm - Naples
- Sarasota Memorial Hospital - Sarasota
Georgia
- Piedmont Augusta Hospital - Augusta
- Augusta University - Augusta
- Northside Hospital - Gainesville
- Northeast Georgia Heart Center, Inc. - Gainesville
Alabama
- Grandview Medical Center - Affinity Hospital, LLC - Birmingham
- Mobile Infirmary - Mobile
Arkansas
- Arrhythmia Research Group - Jonesboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 525 participants |
| Start Date | 2021-03-20 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT04790344 still lists
NCT04790344 is an interventional study that assigns participants to a tested intervention. The registered 525 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Investigational LUX-Dx ICM Implant is the first listed.
NCT04790344 names 20 study sites across 5 states, led by California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT04790344 about?
NCT04790344 is a clinical study titled "LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.". The primary objective of this study is to collect sensor data from insertable cardiac monitor systems.
What is the current status of trial NCT04790344?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 525 participants. The study started on 2021-03-20. Estimated completion is 2026-06.
What conditions does trial NCT04790344 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT04790344?
The interventions under investigation include: Investigational LUX-Dx ICM Implant (DEVICE).
Who is sponsoring clinical trial NCT04790344?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04790344 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04790344's enrollment target sits among peer trials
525 97th of 397 higher than 301 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04769492 · 525 participants · NA
#ChopViolence/#ChopHIV
- NCT05260047 · 525 participants · NA
Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population
- NCT05620719 · 525 participants · NA
Multisite Advancement of Research on Chronic Posttraumatic Headache
- NCT06496646 · 525 participants · NA
Antidepressant Adherence for Depressed Adults in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI